Delivery Order 36F79723D0016-36C24724N0635

Award Date 5/8/24
Potential Completion Date 9/30/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducers, device rentals, and related support services. The $16,582.91 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which was awarded in November 2022 and runs through October...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $16,582.91 firm-fixed-price delivery order is for the provision of Optune Plus transducers, device rentals, and related support services. The contract, under the VA VHA's 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with a $28.85 million ceiling, supports the VA's efforts to...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is part of a larger $28.85 million Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) that Novocure holds with...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 Firm Fixed Price delivery order contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. The contract supports the VA's mission of expanding veterans' access to innovative cancer therapies by enabling VA medical centers...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price delivery order contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is issued under Novocure's existing 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. The contract has a period of performance through June 26, 2024. Novocure's Optune system delivers alternating electric fields to disrupt solid...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. The award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which provides a streamlined...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $99,497.46 firm-fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. The award is issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million....

This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $45,600.00 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services to VA medical centers nationwide. The contract is part of a larger 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with a ceiling value of $28.85 million, awarded to Novocure in November 2022. The contract does not utilize any set-aside designations. This delivery order supports the VA's mission of expanding veterans' access to innovative cancer therapies, enabling VA facilities to offer Novocure's non-invasive Tumor Treating Fields (TTFields) therapy to veteran patients diagnosed with glioblastoma, mesothelioma, and other solid tumor cancers.

Generated 2/14/25, 9:18 AM